We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Skin-Ulcer Treatment Market to Grow

By HospiMedica staff writers
Posted on 18 Sep 2007
The market for skin ulcer treatments will see solid growth over the next four years due to demographic shifts and new treatments such as negative wound pressure therapy, sending the market to US$6.2 billion in 2011, according to a new report.

Overall steady growth in the worldwide skin ulcer treatment market will likely come from new therapies that result in decreasing healing times and subsequent cost savings; a growing focus on special populations such as diabetics and the obese; an increasing elderly population; availability of new therapeutic techniques; and the recent focus on wound care products and prevention, according to a new report by Kalorama Information (New York, NY, USA).

Mature skin treatment products such as anti-infectives, skin ulcer management, and pressure relief devices will continue to generate the majority of sales, but advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. Additionally, negative pressure wound therapy--the use of vacuum pressure within a foam sponge and adhesive wrap, which stimulates blood flow and promotes faster healing--is a segment expected to boost market sales with another dose of significant growth, estimated at 11.6%.

"Developments in treatments of skin ulcers have made tremendous strides in the last decade,” said report author analyst Mary Anne Crandall. "New developments are providing the health care arena of today with some truly sophisticated, highly effective skin ulcer treatments. Revolutionary advances using tissue engineering, growth factors, animal-fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience acute and chronic skin ulcers.”

Kalorama Information is a company that provides market research reports for pharmaceuticals, medical devices, diagnostics, biotechnology, and healthcare


Related Links:
Kalorama Information

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Automated External Defibrillator
HeartStart OnSite AED
New
EBUS-TBNA Endoscope
BF-UC190F

Latest Hospital News News

Nurse Tracking System Improves Hospital Workflow

New Children’s Hospital Transforms California Healthcare

Noisy Hospitals Face Threat of Decreased Federal Compensation